| Characterization of the tumor immune microenvironment identifies M0 macrophage-enriched cluster as a poor prognostic factor in hepatocellular carcinoma M Farha, NK Jairath, TS Lawrence, I El Naqa JCO Clinical Cancer Informatics 4, 1002-1013, 2020 | 38 | 2020 |
| Biomarkers for prostate cancer detection and risk stratification MW Farha, SS Salami Therapeutic advances in urology 14, 17562872221103988, 2022 | 34 | 2022 |
| Prognostic value of intratumoral lymphocyte-to-monocyte ratio and M0 macrophage enrichment in tumor immune microenvironment of melanoma NK Jairath, MW Farha, R Jairath, PW Harms, LC Tsoi, T Tejasvi Melanoma Management 7 (4), MMT51, 2020 | 15 | 2020 |
| Food effect study design with oral drugs: lessons learned from recently approved drugs in oncology M Farha, E Masson, H Tomkinson, G Mugundu The Journal of Clinical Pharmacology 59 (4), 463-471, 2019 | 15 | 2019 |
| Tumor immune microenvironment clusters in localized prostate adenocarcinoma: prognostic impact of macrophage enriched/plasma cell non-enriched subtypes NK Jairath, MW Farha, S Srinivasan, R Jairath, MD Green, RT Dess, ... Journal of Clinical Medicine 9 (6), 1973, 2020 | 13 | 2020 |
| The lack of a physical exam during new patient telehealth visits does not impact plans for office and operating room procedures NW Eyrich, JJ Andino, RE Ukavwe, MW Farha, AK Patel, D Triner, ... Urology 167, 109-114, 2022 | 12 | 2022 |
| Prostate cancer with peritoneal carcinomatosis: a robotic-assisted radical prostatectomy-based case series SB Goldenthal, MA Reimers, U Singhal, M Farha, R Mehra, M Piert, ... Urology 167, 171-178, 2022 | 5 | 2022 |
| MP60-05 MOLECULAR PROFILING OF PROSTATE CANCER REVEALS INCREASED INFLAMMATORY MARKERS AND POOR CLINICAL OUTCOMES IN AFRICAN AMERICAN COMPARED TO EUROPEAN AMERICAN MEN U Singhal, S Nallandhighal, S Bolton, M Farha, J Strangl-Kremser, ... Journal of Urology 206 (Supplement 3), e1042-e1043, 2021 | 2 | 2021 |
| Characterizing PD-L1/PD-1 expression in hepatocellular carcinoma and implications on postresection treatment response. M Farha, M Green, I El Naqa Journal of Clinical Oncology 37 (15_suppl), e15626-e15626, 2019 | 2 | 2019 |
| Analysis of the tumor immune microenvironment (TIME) in clear cell renal cell carcinoma (ccRCC) reveals an M0 macrophage-enriched subtype: an exploration of prognostic and … M Farha, S Nallandhighal, R Vince, B Cotta, J Stangl-Kremser, D Triner, ... Cancers 15 (23), 5530, 2023 | 1 | 2023 |
| Prognostic value and therapeutic implications of an integrative molecular subtype and immune content classifier in localized muscle-invasive bladder cancer. M Farha, B Cotta, R Vince, S Nallandhighal, SD Kaffenberger, P Palmbos, ... Journal of Clinical Oncology 40 (6_suppl), 530-530, 2022 | 1 | 2022 |
| 692P Characterization of the tumor immune microenvironment in early-stage clear cell renal cell carcinoma (ccRCC): Prognostic value of an M0-macrophage enriched subtype M Farha, R Vince, S Nallandinghal, J Stangl-Kremser, D Triner, T Morgan, ... Annals of Oncology 32, S707, 2021 | 1 | 2021 |
| Characterization of the tumor immune microenvironment in clear cell renal cell carcinoma (ccRCC): Prognostic value and therapeutic implications of an M0-macrophage enriched … M Farha, R Vince, S Nallandhighal, J Stangl-Kremser, S Goldenthal, ... Journal of Clinical Oncology 39 (15_suppl), 4572-4572, 2021 | 1 | 2021 |
| 996P Characterization of the tumor immune microenvironment in hepatocellular carcinoma: Prognostic value of M0-macrophage high subtype M Farha, NK Jairath, I El Naqa, T Lawrence Annals of Oncology 31, S694, 2020 | 1 | 2020 |
| Food effect studies and drug label recommendations: A review of recently approved oncology products. M Farha, E Masson, H Tomkinson, G Mugundu Journal of Clinical Oncology 35 (15_suppl), 2535-2535, 2017 | 1 | 2017 |
| The effect of resting dendritic cells on overall survival in the hepatocellular carcinoma tumor microenvironment. P Hanona, N Jairath, M Farha, L Yohanathan, D Ezekwudo, IA Jaiyesimi Journal of Clinical Oncology 42 (16_suppl), e14559-e14559, 2024 | | 2024 |
| MP16-13 ANALYSIS OF THE TUMOR MICROENVIRONMENT (TME) IN HIGH-GRADE TA (HG TA) BLADDER CANCER REVEALS AN IMMUNE AND STROMAL ENRICHED SUBTYPE WHICH DEMONSTRATES POOR PROGNOSIS … M Farha, J Tallman, E Pietzak Journal of Urology 211 (5S), e245, 2024 | | 2024 |
| PD01-12 PAN-CANCER CHARACTERIZATION OF THE TUMOR MICROENVIRONMENT REVEALS STROMA AND IMMUNE ENRICHED SUBTYPE WITH DISTINCT MOLECULAR, CLINICAL, AND PROGNOSTIC FEATURES IN … M Farha, B Cotta, S Nallandhighal, K Hu, S Goldenthal, A Udager, ... Journal of Urology 207 (Supplement 5), e34, 2022 | | 2022 |
| Characterization of the tumor immune microenvironment between primary and paired asynchronous metastatic clear cell renal cell carcinoma BH Cotta, S Nallandhighal, R Mehra, M Cieslik, MW Farha, A Kasputis, ... European Urology 81, S1645, 2022 | | 2022 |
| PD40-01 CHARACTERIZATION OF THE TUMOR IMMUNE MICROENVIRONMENT IN CLEAR CELL RENAL CELL CARCINOMA (CCRCC): PROGNOSTIC VALUE AND THERAPEUTIC IMPLICATIONS OF AN M0-MACROPHAGE … M Farha, R Vince, S Nallandhighal, J Stangl-Kremser, S Goldenthal, ... Journal of Urology 206 (Supplement 3), e674, 2021 | | 2021 |
